Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
48.23
-0.73 (-1.49%)
Nov 21, 2024, 11:49 AM EST - Market open
Janux Therapeutics Employees
Janux Therapeutics had 64 employees as of December 31, 2023. The number of employees increased by 4 or 6.67% compared to the previous year.
Employees
64
Change (1Y)
4
Growth (1Y)
6.67%
Revenue / Employee
$203,891
Profits / Employee
-$945,875
Market Cap
2.53B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 64 | 4 | 6.67% |
| Dec 31, 2022 | 60 | 27 | 81.82% |
| Dec 31, 2021 | 33 | 21 | 175.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardent Health Partners | 23,000 |
| Amneal Pharmaceuticals | 7,850 |
| QuidelOrtho | 7,100 |
| Privia Health Group | 1,102 |
| Twist Bioscience | 919 |
| Iovance Biotherapeutics | 557 |
| Catalyst Pharmaceuticals | 167 |
| Scholar Rock Holding | 150 |
JANX News
- 2 days ago - Janux Therapeutics: Believable Theory, Strong Early Data, Needs Confirmation - Seeking Alpha
- 14 days ago - Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - Business Wire
- 3 months ago - Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Business Wire
- 4 months ago - Janux Therapeutics Announces Updates to Board of Directors - Business Wire
- 5 months ago - Janux Therapeutics: Promising T-Cell Engager Platform In Cancer Therapy - Seeking Alpha
- 7 months ago - Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - Business Wire
- 7 months ago - Janux Therapeutics (JANX) stock has gone parabolic: what next? - Invezz
- 8 months ago - Janux Therapeutics: A Prime Target In Cancer Care's M&A Game - Seeking Alpha